Pilot study of interferon‐α–ribavirin–interleukin‐2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1
暂无分享,去创建一个
J. Izopet | J. Vinel | J. Péron | L. Alric | B. Pipy | S. Métivier | S. Thébault | P. Balard | Patricia Balard